|
Volumn 124, Issue 11, 2014, Pages 1737-1747
|
Downregulation of Prdm16 mRNA is a specific antileukemic mechanism during HOXB4-mediated HSC expansion in vivo.
a b a a b b a b |
Author keywords
[No Author keywords available]
|
Indexed keywords
DNA BINDING PROTEIN;
HOMEODOMAIN PROTEIN;
HOXA10 PROTEIN, MOUSE;
HOXB4 PROTEIN, MOUSE;
MESSENGER RNA;
PRDM16 PROTEIN, MOUSE;
TRANSCRIPTION FACTOR;
TRANSCRIPTION FACTOR HOXA9;
TUMOR PROTEIN;
ACUTE GRANULOCYTIC LEUKEMIA;
ANIMAL;
ARTICLE;
B LYMPHOCYTE;
BIOSYNTHESIS;
BONE MARROW CELL;
CELL DIFFERENTIATION;
CELL TRANSFORMATION;
CYTOLOGY;
DOWN REGULATION;
FEMALE;
GENE EXPRESSION REGULATION;
GENETIC TRANSCRIPTION;
GENETIC TRANSDUCTION;
GENETICS;
HEMATOPOIETIC STEM CELL;
HUMAN;
METABOLISM;
MOUSE;
PHYSIOLOGY;
ANIMALS;
B-LYMPHOCYTES;
CELL DIFFERENTIATION;
CELL TRANSFORMATION, NEOPLASTIC;
DNA-BINDING PROTEINS;
DOWN-REGULATION;
FEMALE;
GENE EXPRESSION REGULATION, LEUKEMIC;
HEMATOPOIETIC STEM CELLS;
HOMEODOMAIN PROTEINS;
HUMANS;
LEUKEMIA, MYELOID, ACUTE;
MICE;
MYELOID CELLS;
NEOPLASM PROTEINS;
RNA, MESSENGER;
TRANSCRIPTION FACTORS;
TRANSCRIPTION, GENETIC;
TRANSDUCTION, GENETIC;
MLCS;
MLOWN;
|
EID: 84908613134
PISSN: None
EISSN: 15280020
Source Type: Journal
DOI: 10.1182/blood-2013-10-534735 Document Type: Article |
Times cited : (19)
|
References (0)
|